Powered Exoskeletons in Persons With SCI
(PEPSCI)
CSP #2003 - Exoskeleton Assisted-Walking in Persons With SCI: Impact on Quality of Life
1 other identifier
interventional
424
1 country
15
Brief Summary
Background Veterans with spinal cord injury (SCI) have many adverse secondary medical and quality of life (QOL) changes as a result of immobilization. Veterans with SCI who have completed rehabilitation after injury and are unable to ambulate receive a wheelchair as standard of care (SOC) for mobility. Powered exoskeletons are a technology that has recently become available as an alternate form of mobility by providing an external framework for support and computer controlled motorized hip and knee joints to assist with over ground ambulation.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Aug 2016
Longer than P75 for not_applicable
15 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
January 6, 2016
CompletedFirst Posted
Study publicly available on registry
January 20, 2016
CompletedStudy Start
First participant enrolled
August 1, 2016
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 31, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
September 30, 2021
CompletedResults Posted
Study results publicly available
June 6, 2022
CompletedNovember 4, 2024
October 1, 2024
4.7 years
January 6, 2016
March 30, 2022
October 23, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Improvement on the MCS in All Randomized Participants
Number of randomized participants with a greater than or equal to 4 point change on the Mental Health Component Summary (MCS) of the Veterans Rand-36 (VR-36) from Baseline Assessment to 4 Months Post Intervention. Possible range of the MCS is 0 to 100, with a higher score indicating higher mental wellbeing.
Change from Baseline Assessment to 4 Months Post Intervention
Improvement on the SCI-QOL Physical Medical Health Domain in All Randomized Participants
Number of randomized participants with a greater than or equal to 10 percent decrease on the SCI-QOL Physical Medical Health Domain (PMH) from Baseline Assessment to 4 Months Post Intervention. The PMH score is a sum of the SCI-QOL scores from the Bladder Management Difficulties, Bowel Management Difficulties, and Pain Interference item banks. Possible range of the PMH score is 110 to 253, with a lower score indicating better physical medical wellbeing.
Change from Baseline Assessment to 4 Months Post Intervention
Secondary Outcomes (27)
Total Body Fat Loss in All Randomized Participants
4 months post intervention
Improvement on the Mental Health Component Summary (MCS) in Participants Who Completed the 4 Month Intervention Phase.
4 months post intervention
Improvement on the SCI-QOL Physical Medical Health Domain in Participants Who Completed the 4 Month Intervention Phase.
4 months post intervention
Total Body Fat Loss in Participants Who Completed the 4 Month Intervention Phase.
4 months post intervention
Change in Mental Health Component Summary (MCS)
post training/orientation, two months post intervention, and 4 months post intervention.
- +22 more secondary outcomes
Study Arms (2)
Exoskeleton + Standard of Care (SOC)
ACTIVE COMPARATORPatient will receive exoskeletal-assisted walking device for in home use for 4 months
Standard of Care (SOC)
NO INTERVENTIONPatient will receive standard of care (wheelchair use)
Interventions
Eligibility Criteria
You may qualify if:
- Veterans or active duty military personnel who are at least 18 years of age;
- Traumatic or non-traumatic SCI 6 months duration of SCI;
- Wheelchair-user for indoor and outdoor mobility;
- Anthropometric compatibility with the device:
- Weight \<220 lb. (100 kg),
- Thigh length between 14 and 19 in (36 and 48 cm),
- Shank length between 17 and 22 in (43 and 55 cm);
- Able to hold the crutches in hands without modifications;
- Able to have a companion who can attend approximately one-third of the training sessions who will assist them at home and in the community; and
- Able to provide informed consent.
You may not qualify if:
- Diagnosis of neurological injury other than SCI;
- Progressive condition that would be expected to result in changing neurological status;
- Severe concurrent medical disease, illness or condition judged to be contraindicated by the Site Physician;
- Knee BMD \< 0.60 gm/cm2;
- Total hip BMD T-scores \< -3.5;
- Fragility, minimal trauma or low impact fracture of the lower extremity since spinal cord injury (definition below);
- Untreatable severe spasticity judged to be contraindicated by the Site Physician;
- Flexion contracture \> 15 degrees at the hip and/or \> 10 degrees at the knee;
- Limitations in ankle range of motion that cannot be adapted with an orthotic device (plantar flexion \> 00);
- Untreated or uncontrolled hypertension (systolic blood pressure \>140 mmHg; diastolic blood pressure \>90 mmHg);
- Unresolved orthostatic hypotension (systolic blood pressure \<90 mmHg; diastolic blood pressure \<60 mmHg) as judged to be contraindicated by the Site Physician;
- Current pressure ulcer of the arms, trunk, pelvic area, or lower extremities;
- Psychopathology documentation in the medical record or history that may conflict with study objectives; and/or
- Pregnancy or women who plan to become pregnant during the study period.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (15)
VA Long Beach Healthcare System, Long Beach, CA
Long Beach, California, 90822, United States
VA Palo Alto Health Care System, Palo Alto, CA
Palo Alto, California, 94304-1290, United States
James A. Haley Veterans' Hospital, Tampa, FL
Tampa, Florida, 33612, United States
Charlie Norwood VA Medical Center, Augusta, GA
Augusta, Georgia, 30904, United States
VA Boston Healthcare System Jamaica Plain Campus, Jamaica Plain, MA
Boston, Massachusetts, 02130, United States
Minneapolis VA Health Care System, Minneapolis, MN
Minneapolis, Minnesota, 55417, United States
St. Louis VA Medical Center John Cochran Division, St. Louis, MO
St Louis, Missouri, 63106, United States
New Mexico VA Health Care System, Albuquerque, NM
Albuquerque, New Mexico, 87108-5153, United States
James J. Peters VA Medical Center, Bronx, NY
The Bronx, New York, 10468-3904, United States
Louis Stokes VA Medical Center, Cleveland, OH
Cleveland, Ohio, 44106, United States
VA North Texas Health Care System Dallas VA Medical Center, Dallas, TX
Dallas, Texas, 75216, United States
Michael E. DeBakey VA Medical Center, Houston, TX
Houston, Texas, 77030, United States
South Texas Health Care System, San Antonio, TX
San Antonio, Texas, 78229, United States
Hunter Holmes McGuire VA Medical Center, Richmond, VA
Richmond, Virginia, 23249, United States
Clement J. Zablocki VA Medical Center, Milwaukee, WI
Milwaukee, Wisconsin, 53295-1000, United States
Related Publications (1)
Spungen AM, Dematt EJ, Biswas K, Jones KM, Mi Z, Snodgrass AJ, Morin K, Asselin PK, Cirnigliaro CM, Kirshblum S, Gorman PH, Goetz LL, Stenson K, White KT, Hon A, Sabharwal S, Kiratli BJ, Ota D, Bennett B, Berman JE, Castillo D, Lee KK, Eddy BW, Henzel MK, Trbovich M, Holmes SA, Skelton F, Priebe M, Kornfeld SL, Huang GD, Bauman WA. Exoskeletal-Assisted Walking in Veterans With Paralysis: A Randomized Clinical Trial. JAMA Netw Open. 2024 Sep 3;7(9):e2431501. doi: 10.1001/jamanetworkopen.2024.31501.
PMID: 39230903RESULT
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Results Point of Contact
- Title
- Dr. Ann Spungen, Study Chairperson
- Organization
- James J Peters VA Medical Center
Study Officials
- STUDY CHAIR
Ann M Spungen, EdD
James J. Peters Veterans Affairs Medical Center
Publication Agreements
- PI is Sponsor Employee
- Yes
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- FED
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
January 6, 2016
First Posted
January 20, 2016
Study Start
August 1, 2016
Primary Completion
March 31, 2021
Study Completion
September 30, 2021
Last Updated
November 4, 2024
Results First Posted
June 6, 2022
Record last verified: 2024-10
Data Sharing
- IPD Sharing
- Will not share
Individual Participant Data will not be shared.